Turnstone Biologics Azioni (NASDAQ: TSBX)

Ultime notizie per Turnstone Biologics (NASDAQ:TSBX) Azioni

Turnstone Biologics

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Turnstone Biologics Corp

News

ALGT

Allegiant Travel April Load Factor Down 2.1pts To 80.3% From 82.4% Last Year

Raymond James analyst Brent Penter reiterates Starz Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRZ#NASDAQ">STRZ</a>) with a Outperform and raises the price target from $19 to $22.

Price Target

Reiteration

Analyst Ratings

STRZ

Raymond James Reiterates Outperform on Starz Entertainment, Raises Price Target to $22

Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) shares have been volatile in recent sessions amid broader EV market turbulence, despite long-term optimism surrounding its upcoming R2 model. 
What To Know: The recent downturn across EV stocks follows the House passage of President Donald Trump's "Big Beautiful Bill," which <a href="https://www.benzinga.com/25/05/45586258/is-trumps-big-beautiful-bill-a-major-roadblock-for-elon-musks-tesla-and-other-evs">proposes eliminating</a> the $7,500 federal EV tax credit for high-volume automakers, among other policy rollbacks.
Despite this political uncertainty, analysts are <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45617151/ubs-maintains-neutral-rating-for-rivian-stock-sets-price-13-price-target">cautiously optimistic</a> about Rivian. UBS raised its price target from $12 to $13, maintaining a Neutral rating, citing the affordable R2 SUV, slated for 2026 with a ~$45,000 price tag, as a key growth driver. 
CEO RJ Scaringe this week <a href="https://www.benzinga.com/25/05/45642153/rivian-ceo-rj-scaringe-touts-45000-rivian-r2s-updated-rear-suspension-cant-wait-for-folks">showcased</a> the R2&#8217;s innovative multi-link rear suspension, emphasizing cost-efficient engineering and enhanced ride quality.
Rivian is also investing $120 million to expand its Illinois facility, potentially adding hundreds of jobs. A $5.8 billion collaboration with Volkswagen to build a budget EV further strengthens its strategic outlook. 
While tariff concerns have led Rivian to cut its 2025 delivery forecast, a strong first-quarter performance and growing investor confidence keep the stock on steadier footing.
Read Also: <a href="https://www.benzinga.com/cannabis/25/05/45698481/galaxy-digital-glxy-shares-slide-5-following-upsized-public-offering-announcement">Galaxy Digital Shares Slide 5% Following Upsized Public Offering Announcement</a> Price Action: RIVN shares are trading lower by 2.6% to $14.62 Friday afternoon. The stock is lower by 5.8% over the trailing week.
<h2 class="wp-block-heading">How To Buy RIVN Stock</h2>
By now you're likely curious about how to participate in the market for Rivian Automotive &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Rivian Automotive, which is trading at $14.83 as of publishing time, $100 would buy you 6.74 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RIVN has a 52-week high of $18.86 and a 52-week low of $9.50.
Image: Shutterstock

RIVN

Rivian (RIVN) Stock Is Volatile: What's Going On?

Raymond James analyst Srini Pajjuri reiterates Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Outperform and lowers the price target from $110 to $90.

MRVL

Raymond James Reiterates Outperform on Marvell Tech, Lowers Price Target to $90

<a href="https://www.bloomberg.com/news/articles/2025-05-30/rivian-eyes-new-debt-deal-as-expected-vehicle-deliveries-slump?srnd=homepage-americas&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/rivian-eyes-new-debt-deal-as-expected-vehicle-deliveries-slump?srnd=homepage-americas&amp;embedded-checkout=true</a>

General

'Rivian Eyes New Debt Deal as Expected Vehicle Deliveries Slump'- Bloomberg

Raymond James analyst Simon Leopold maintains Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) with a Outperform and raises the price target from $144 to $150.

DELL

Raymond James Maintains Outperform on Dell Technologies, Raises Price Target to $150

Raymond James analyst John Freeman reiterates APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) with a Outperform and raises the price target from $23 to $25.

Raymond James Reiterates Outperform on APA, Raises Price Target to $25

Zscaler, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) stock is trading higher Friday after the company reported better-than-expected first-quarter financial results on Thursday after the market closed and raised its fiscal-<a href="https://www.benzinga.com//node/45680852">year 2025 guidance</a>.
What To Know: The company posted adjusted earnings per share of 84 cents, beating the consensus estimate of 75 cents. In addition, Zscaler, reported sales of $678.03 million, beating the consensus estimate of $666.86 million, and representing a 23% year-over-year climb.
The company ended the quarter with $3.0 billion in cash and cash equivalents, an increase of $595.9 million, compared to the same time period last year.
&#8220;We delivered outstanding&nbsp;Q3&nbsp;results as an increasing number of customers adopt our expanding Zero Trust Exchange platform. We enable customers to realize Zero Trust Everywhere while lowering operational cost and complexity,&#8221; said Jay Chaudhry, Chairman and CEO of Zscaler.&nbsp;
Zscaler announced that it appointed Kevin Rubin as CFO. Rubin is set to succeed Remo Canessa, who announced plans to retire last year.
Outlook: The company sees fourth-quarter sales of $705 million to $707 million, versus the consensus estimate of $707.61 million. For fiscal-year 2025, Gap now sees adjusted earnings per share from $3.18 to $3.19, versus the consensus estimate of $3.07.
The company previously anticipated adjusted earnings per share from $3.04 to $3.09. Gap now expects sales of $2.66 billion, versus the consensus estimate of $2.65 billion. It previously saw sales from $2.64 billion to $2.65 billion.
Analyst Changes: Following the earnings report, multiple analysts announced price target adjustments.
<ul class="wp-block-list">
<li>JMP Securities analyst Trevor Walsh maintained a Market Outperform rating and raised the price target from $240 to $310.</li>
<li>Keybanc analyst Eric Heath maintained an Overweight rating and raised the price target from $290 to $310.</li>
<li>UBS analyst Roger Boyd maintained a Buy rating and raised the price target from $260 to $315.</li>
<li>Wells Fargo analyst Andrew Nowinski maintained an Equal-Weight rating and raised the price target from $210 to $260.</li>
</ul>
Related Link: <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45695903/ulta-stock-is-rising-friday-whats-going-on">Ulta Stock Is Rising Friday: What&#8217;s Going On?</a>
ZS Price Action: At the time of publication, Zscaler stock is trading 8.53% higher at $272.63, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwjTpP_ircuNAxVCpIkEHV7jF6UQFnoECAsQAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro.</a>
Image: via Shutterstock

Movers

Zscaler Stock Is Gaining Friday: What's Going On?

Evercore ISI Group analyst Peter Levine maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Outperform and raises the price target from $245 to $290.

Evercore ISI Group Maintains Outperform on Zscaler, Raises Price Target to $290

Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) posted better-than-expected earnings for the <a href="https://www.benzinga.com/quote/BURL/earnings">first quarter on Thursday</a>.
The company reported first-quarter adjusted earnings per share of $1.60, beating the analyst consensus estimate of $1.41. Quarterly sales of $2.50 billion missed the Street view of $2.52 billion.
"We anticipate that tariffs will put significant pressure on our merchandise margin, but we are confident that, as long as tariffs do not increase from current levels, we can offset this pressure elsewhere in the P&amp;L," said the company's CEO Michael O'Sullivan.
Burlington Stores sees second-quarter adjusted EPS of $1.20-$1.30 versus the $1.34 estimate. The firm expects total sales to increase in the range of 5% to 7%; this assumes comparable store sales will increase in the range of 0% to 2%.
For FY25, the firm expects total sales to increase in the range of 6% to 8% on top of the 11% increase during Fiscal 2024.
Burlington shares fell 0.7% to trade at $226.17 on Friday.
These analysts made changes to their price targets on Burlington following earnings announcement.
<ul class="wp-block-list">
<li>Telsey Advisory Group analyst Dana Telsey maintained Burlington Stores with an Outperform rating and lowered the price target from $340 to $300.</li>
<li>Barclays analyst Adrienne Yih maintained the stock with an Overweight rating and raised the price target from $254 to $299.</li>
<li>Evercore ISI Group analyst Michael Binetti maintained Burlington Stores with an Outperform rating and lowered the price target from $345 to $310.</li>
</ul>
Considering buying BURL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/BURL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30130608/image-419-1024x535.png" alt="" class="wp-image-933555" style="width:683px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30130608/image-419-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30130608/image-419-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30130608/image-419-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30130608/image-419.png 1093w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45691209/top-3-materials-stocks-that-could-blast-off-this-month-2">Top 3 Materials Stocks That Could Blast Off This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

BURL

These Analysts Revise Their Forecasts On Burlington Stores After Q1 Results

Evercore ISI Group analyst Michael Binetti maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Outperform and raises the price target from $465 to $490.

ULTA

Evercore ISI Group Maintains Outperform on Ulta Beauty, Raises Price Target to $490

<h3>Gainers</h3>
<ul>
<li>Global Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) shares moved upwards by 108.4% to $1.98 during Friday's regular session. The market value of their outstanding shares is at $5.2 million. </li>
<li>Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) shares moved upwards by 35.28% to $0.21. The market value of their outstanding shares is at $5.1 million. </li>
<li>Starz Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRZ#NASDAQ">STRZ</a>) shares moved upwards by 19.24% to $19.69. The market value of their outstanding shares is at $328.9 million. </li>
<li>Mega Matrix (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MPU#AMEX">MPU</a>) stock rose 11.25% to $0.97. The market value of their outstanding shares is at $39.4 million. </li>
<li>Able View Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABLV#NASDAQ">ABLV</a>) stock rose 9.73% to $1.24. The company's market cap stands at $61.2 million. </li>
<li>Haoxi Health Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares increased by 9.28% to $1.53. The company's market cap stands at $4.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CTRL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCTR#NASDAQ">MCTR</a>) shares fell 19.6% to $4.72 during Friday's regular session. The company's market cap stands at $72.2 million. </li>
<li>AirNet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) stock fell 17.75% to $0.7. The market value of their outstanding shares is at $10.0 million. </li>
<li>Newsmax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMAX#NYSE">NMAX</a>) shares decreased by 17.05% to $18.52. The market value of their outstanding shares is at $2.3 billion. </li>
<li>QMMM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) stock fell 16.16% to $1.09. The market value of their outstanding shares is at $18.7 million. </li>
<li>Arena Group Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AREN#AMEX">AREN</a>) stock fell 15.73% to $4.02. The company's market cap stands at $191.1 million. </li>
<li>Phoenix New Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) stock declined by 11.77% to $2.1. The company's market cap stands at $25.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABLV

ANTE

AREN

FENG

GITS

MCTR

NMAX

QMMM

12 Communication Services Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares rose 171.6% to $2.83 during Friday's regular session. The market value of their outstanding shares is at $53.0 million. </li>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) stock moved upwards by 50.92% to $5.72. The market value of their outstanding shares is at $21.2 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) shares moved upwards by 39.78% to $2.78. The company's market cap stands at $48.7 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock moved upwards by 23.48% to $915.0. The company's market cap stands at $11.9 billion. </li>
<li>Spero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRO#NASDAQ">SPRO</a>) shares rose 23.0% to $2.62. The company's market cap stands at $146.4 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares rose 20.47% to $1.74. The market value of their outstanding shares is at $3.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) stock fell 29.5% to $3.2 during Friday's regular session. The market value of their outstanding shares is at $36.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) shares declined by 29.48% to $18.48. The market value of their outstanding shares is at $13.7 billion. </li>
<li>Alzamend Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) stock fell 28.41% to $3.9. The market value of their outstanding shares is at $2.8 million. </li>
<li>Harvard Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBIO#NASDAQ">HBIO</a>) shares decreased by 27.38% to $0.49. The market value of their outstanding shares is at $21.5 million. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) stock declined by 24.29% to $0.46. The market value of their outstanding shares is at $22.5 million. </li>
<li>EXoZymes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXOZ#NASDAQ">EXOZ</a>) shares decreased by 21.01% to $10.98. The company's market cap stands at $91.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALZN

ASBP

BLRX

BMGL

CLGN

EXOZ

HBIO

IMNN

SMMT

SPRO

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) stock increased by 93.0% to $0.39 during Friday's regular session. The company's market cap stands at $20.4 million. </li>
<li>ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) shares moved upwards by 64.63% to $1.35. The market value of their outstanding shares is at $16.3 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares increased by 34.0% to $1.03. The market value of their outstanding shares is at $33.6 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock moved upwards by 26.8% to $0.31. The company's market cap stands at $71.0 million. </li>
<li>Li Bang International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBGJ#NASDAQ">LBGJ</a>) shares rose 18.05% to $1.7. The company's market cap stands at $31.8 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock increased by 16.93% to $5.73. The company's market cap stands at $12.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Huachen AI Parking Mgmt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAI#NASDAQ">HCAI</a>) shares fell 22.2% to $6.4 during Friday's regular session. The market value of their outstanding shares is at $215.9 million. </li>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) stock decreased by 19.63% to $1.15. The market value of their outstanding shares is at $57.5 million. </li>
<li>Babcock &amp; Wilcox Enterprises, Inc. 6.50% Senior Notes due 2026 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWNB#NYSE">BWNB</a>) shares decreased by 19.1% to $10.51. </li>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) stock decreased by 13.71% to $2.96. The market value of their outstanding shares is at $41.5 million. As per the press release, Q4 earnings came out 3 days ago. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares declined by 13.5% to $1.09. The company's market cap stands at $7.7 million. </li>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) stock decreased by 12.54% to $2.9. The market value of their outstanding shares is at $63.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BURU

BWNB

CAPT

ELPW

GPUS

HCAI

LBGJ

LNZA

SGBX

WETO

12 Industrials Stocks Moving In Friday's Intraday Session

Evercore ISI Group analyst David Motemaden maintains Palomar Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLMR#NASDAQ">PLMR</a>) with a In-Line and raises the price target from $163 to $168.

PLMR

Evercore ISI Group Maintains In-Line on Palomar Hldgs, Raises Price Target to $168

<h3>Gainers</h3>
<ul>
<li>Verb Technology Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) shares increased by 14.8% to $7.46 during Friday's regular session. The market value of their outstanding shares is at $10.5 million. </li>
<li>Lianhe Sowell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LHSW#NASDAQ">LHSW</a>) shares moved upwards by 14.55% to $2.46. The company's market cap stands at $128.0 million. </li>
<li>Interlink Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINK#NASDAQ">LINK</a>) stock increased by 14.05% to $6.94. The market value of their outstanding shares is at $68.4 million. </li>
<li>TSS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) shares increased by 9.35% to $13.39. The company's market cap stands at $334.9 million. </li>
<li>Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) stock increased by 8.2% to $271.71. The company's market cap stands at $42.0 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) stock increased by 8.11% to $0.33. The company's market cap stands at $21.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) stock declined by 38.9% to $0.85 during Friday's regular session. The market value of their outstanding shares is at $27.2 million. </li>
<li>AMTD Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) stock fell 21.3% to $2.07. The company's market cap stands at $650.5 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares decreased by 18.9% to $2.06. The company's market cap stands at $7.4 million. </li>
<li>Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) stock declined by 17.67% to $51.05. The market value of their outstanding shares is at $2.1 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Global Engine Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLE#NASDAQ">GLE</a>) shares declined by 17.31% to $2.39. The company's market cap stands at $43.7 million. </li>
<li>Xunlei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNET#NASDAQ">XNET</a>) shares fell 13.06% to $5.53. The company's market cap stands at $344.9 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMBA

CISO

LHSW

LINK

TDTH

TSSI

VERB

XNET

12 Information Technology Stocks Moving In Friday's Intraday Session

ABBV

NFLX

CORRECTION: CNBC Halftime Report Final Trades: Meta Platforms, Netflix, The Gap, Inc., AbbVie

Evercore ISI Group analyst Kirk Materne maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a In-Line and raises the price target from $11 to $15.

PATH

Evercore ISI Group Maintains In-Line on UiPath, Raises Price Target to $15

Investors with a lot of money to spend have taken a bullish stance on Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ANF, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 14 uncommon options trades for Abercrombie &amp; Fitch.
This isn't normal.
The overall sentiment of these big-money traders is split between 78% bullish and 14%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $114,119, and 10 are calls, for a total amount of $767,992.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $60.0 to $90.0 for Abercrombie &amp; Fitch during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Abercrombie &amp; Fitch options trades today is 287.38 with a total volume of 8,391.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Abercrombie &amp; Fitch's big money trades within a strike price range of $60.0 to $90.0 over the last 30 days.
<h3>Abercrombie &amp; Fitch Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748624636_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.65</td>
<td>$2.6</td>
<td>$2.65</td>
<td>$85.00</td>
<td>$138.0K</td>
<td align="right">660</td>
<td>1.0K</td>
</tr>
<tr>
<td>ANF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.6</td>
<td>$2.55</td>
<td>$2.55</td>
<td>$85.00</td>
<td>$122.1K</td>
<td align="right">660</td>
<td>505</td>
</tr>
<tr>
<td>ANF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$14.1</td>
<td>$13.7</td>
<td>$14.0</td>
<td>$80.00</td>
<td>$81.2K</td>
<td align="right">451</td>
<td>58</td>
</tr>
<tr>
<td>ANF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$24.5</td>
<td>$24.1</td>
<td>$24.49</td>
<td>$60.00</td>
<td>$73.3K</td>
<td align="right">10</td>
<td>30</td>
</tr>
<tr>
<td>ANF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.8</td>
<td>$4.6</td>
<td>$4.65</td>
<td>$81.00</td>
<td>$68.8K</td>
<td align="right">28</td>
<td>152</td>
</tr>
</tbody>
</table>

<h3>About Abercrombie &amp; Fitch</h3>
Abercrombie &amp; Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie &amp; Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
After a thorough review of the options trading surrounding Abercrombie &amp; Fitch, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Abercrombie &amp; Fitch</h3>
<ul>
<li>With a trading volume of 2,287,709, the price of ANF is down by -4.74%, reaching $79.1.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>What The Experts Say On Abercrombie &amp; Fitch</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $104.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Abercrombie &amp; Fitch with a target price of $84. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Abercrombie &amp; Fitch with a target price of $147. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Abercrombie &amp; Fitch with a target price of $78. 
&#x2A; An analyst from Telsey Advisory Group has decided to maintain their Outperform rating on Abercrombie &amp; Fitch, which currently sits at a price target of $125. 
&#x2A; Consistent in their evaluation, an analyst from Raymond James keeps a Outperform rating on Abercrombie &amp; Fitch with a target price of $90. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Abercrombie &amp; Fitch, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Abercrombie & Fitch Unusual Options Activity For May 30

Financial giants have made a conspicuous bullish move on Tesla. Our analysis of options history for Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) revealed 422 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 43% showed bearish tendencies. Out of all the trades we spotted, 120 were puts, with a value of $7,077,828, and 302 were calls, valued at $22,751,336.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $280.0 and $600.0 for Tesla, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Tesla's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tesla's whale trades within a strike price range from $280.0 to $600.0 in the last 30 days. 
<h3>Tesla Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748624632_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$2.05</td>
<td>$2.04</td>
<td>$2.05</td>
<td>$357.50</td>
<td>$293.9K</td>
<td>5.1K</td>
<td>43.6K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$11.6</td>
<td>$11.45</td>
<td>$11.5</td>
<td>$360.00</td>
<td>$172.5K</td>
<td>7.7K</td>
<td>24.5K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$3.1</td>
<td>$3.05</td>
<td>$3.1</td>
<td>$360.00</td>
<td>$156.8K</td>
<td>6.8K</td>
<td>65.9K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$3.35</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$360.00</td>
<td>$138.2K</td>
<td>6.8K</td>
<td>69.7K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/06/25</td>
<td>$6.15</td>
<td>$6.1</td>
<td>$6.1</td>
<td>$350.00</td>
<td>$120.2K</td>
<td>6.6K</td>
<td>10.0K</td>
</tr>
</tbody>
</table>

<h3>About Tesla</h3>
Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.
After a thorough review of the options trading surrounding Tesla, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Tesla's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 57,069,150, the TSLA's price is down by -2.73%, now at $348.64. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 53 days.</li>
</ul>
<h3>Professional Analyst Ratings for Tesla</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $413.33.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wedbush downgraded its action to Outperform with a price target of $350. 
&#x2A; An analyst from Wedbush has decided to maintain their Outperform rating on Tesla, which currently sits at a price target of $500. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for Tesla, targeting a price of $390. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tesla with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

TSLA

A Closer Look at Tesla's Options Market Dynamics

Health Care

Press Releases

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights

Comments

Turnstone Biologics

Notizie

Ultime notizie per Turnstone Biologics (NASDAQ:TSBX) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO